Comparison · NCT05265312-8e6b9d17
Intervention Clinic vs Control Clinic: Number of Participants Who Complete Glycemic Lab Testing Out of Those With an Order During Intervention Period
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Intervention Clinic vs Control Clinic: Number of Participants Who Complete Glycemic Lab Testing Out of Those With an Order During Intervention Period. Trial comparisons, record NCT05265312-8e6b9d17. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT05265312-8e6b9d17
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.916 | 0.896 | 0.933 | wilson | |
| Risk in group 2 | 0.874 | 0.852 | 0.893 | wilson | |
| Risk difference, group 1 minus group 2 | 0.0427 | 0.015 | 0.0699 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 1.05 | 1.02 | 1.08 | log | |
| Odds ratio, group 1 over group 2 | 1.58 | 1.17 | 2.14 | log | |
| Number needed to treat, for one more participant with the outcome on Intervention Clinic than on Control Clinic | 23.4 | 14.3 | 66.4 | from the risk difference interval |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: control.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Intervention Clinic | START diabetes prevention clinical pathway | 800 | 873 | OG000 |
| Group 2 | Control Clinic | Routine usual care | 906 | 1,037 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Number of Participants Who Complete Glycemic Lab Testing Out of Those With an Order During Intervention Period
- Description
- Fasting glucose or Hemoglobin A1c
- Time frame
- 12 months
- Population
Source ClinicalTrials.gov
Trial
- Title
- Implementation and Evaluation of a Diabetes Prevention Clinical Pathway in Primary Care
- NCT number
- NCT05265312
- Phases
- NA
- Conditions
- PreDiabetes, Prediabetic State
- Interventions
- START diabetes prevention clinical pathway
- Lead sponsor
- Johns Hopkins University
- Results first posted
- 2024-06-25
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT05265312?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT05265312-8e6b9d17